新斯的明经足三里注射对胃肠手术患者术后胃肠功能恢复的影响  

Inl uence of Zusanli acupoint injection of neostigmine on gastrointestinal function in patients after gastrointestinal surgery

作　　者：曾涛[1] 李伟学[1] 田宋君[1] 

机构地区：[1]武汉科技大学附属汉阳医院普外科,湖北省武汉市430050

出　　处：《世界华人消化杂志》2015年第24期3955-3959,共5页World Chinese Journal of Digestology

摘　　要：目的:探讨在胃肠道手术后给予新斯的明足三里穴位注射对其胃肠功能恢复的影响.方法:回顾性分析在2006-05/2014-05武汉科技大学附属汉阳医院收治的行胃肠道手术后的300例患者,有A、B、C、D 4组,D组患者给予常规治疗,其余3组患者均在常规治疗基础上给予下述治疗,A组患者联合给予针刺足三里治疗、B组患者联合给予足三里盐水注射治疗、C组患者给予新斯的明足三里穴位注射治疗,每组75例,然后将3组患者的首次排气时间、首次排便时间、肠鸣音恢复时间、胃液量及胃泌素含量等进行比较.结果:在首次排气时间、首次排便时间、肠鸣音恢复时间上C组患者分别为31.2 h±9.5 h、40.6 h±10.7 h、30.6 h±3.4 h,均低于A组(46.9 h±10.1 h、55.7 h±11.8 h、45.1 h±9.6 h)、B组(45.6 h±9.8 h、56.3 h±10.9 h、44.6 h±9.8 h)及D组(51.3 h±10.5 h、56.6 h±12.1 h、50.6 h±9.2 h)(P<0.05);4组患者在治疗前的胃液量和胃泌素上无明显差异(P>0.05);在治疗后,C组患者的胃液量为251.6 m L/d±210.7 m L/d,明显低于A组(540.6 m L/d±391.8 m L/d)、B组(99.3 m L/d±45.6 m L/d)及D组(551.6 m L/d±410.5 m L/d)(P<0.05),C组患者的胃泌素为119.8 n g/L±58.6 ng/L,明显高于A组(95.1 ng/L±43.3n g/L)、B组(99.3 n g/L±45.6 n g/L)及D组(89.8 ng/L±46.6 ng/L)(P<0.05).结论:在胃肠道手术后给予新斯的明足三里穴位注射的治疗方案,能够显著的促进其胃肠功能的恢复,使其早日康复,可以在普外科推广应用.AIM： To investigate the effect of Zusanli injection of neostigmine on gastrointestinal function recovery in patients after gastrointestinal surgery. METHODS： A retrospective analysis was performedof 300 patients who underwent gastrointestinal surgery from July 2006 to July 2014 at Hanyang Hospital. They were equally and divided into four groups： A, B, C, and D. Group D was given conventional treatment, group A was given acupuncture at Zusanli plus conventional treatment, group B was given Zusanli saline injection plus conventional treatment, and group C was given Zusanli acupoint injection of neostigmine plus conventional treatment. The time to f irst anal exhaust, time to f irst defecation, time to recovery of bowel sounds, gastric juice and gastrin content were compared among different groups.RESULTS： The time to first anal exhaust, time to first defecation, and time to recovery of bowel sounds were significantly lower in group C（31.2 h ± 9.5 h, 40.6 h ± 10.7 h, 30.6 h ± 3.4 h） than in group A（46.9 h ± 10.1 h, 55.7 h ± 11.8 h, 45.1 h ± 9.6 h）, group B（45.6 h ± 9.8 h, 56.3 h ± 10.9 h, 44.6 h ± 9.8 h）, and group D（51.3 h ± 10.5 h, 56.6 h ± 12.1 h, 50.6 h ± 9.2 h）（P 〈0.05）. Before treatment, there was no signif icant difference in gastric juice volume and gastrin among the four groups. After treatment, gastric juice volume was signifi cantly lower in group C（251.6 m L/d ± 210.7 m L/d） than in group A（540.6 m L/d ± 391.8 m L/d）, group B（99.3 m L/d ± 45.6 m L/d）, and group D（551.6 m L/d ± 410.5 m L/d）（P 〈0.05）, and gastrin was significantly higher in group C（119.8 ng/L ± 58.6 ng/L） than in group A（95.1 ng/L ± 43.3 ng/L）, group B（99.3 ng/L ± 45.6 ng/L）, and group D（89.8 ng/L ± 46.6 ng/L）（P 〈0.05）. CONCLUSION： Zusanli injection of neostigmineafter gastrointestinal surgery can signifi cantly promote the restoration of gastrointestinal function.

关 键 词：胃肠功能恢复 胃肠道手术 新斯的明 足三里 

分 类 号：R656[医药卫生—外科学]